TrialOncotarget2016

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.

Neil E Kay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.